1

PUBLICACIONES INTERNACIONALES y NACIONALES. SERVICIO DE CARDIOLOGÍA

1. Rodríguez-Entem F, González-Enríquez S, Cobo M, Expósito V, Llano M, Ruiz M, Olalla JJ, Otero-Fernández M. The utility of Implantable Loop Recorders for Diagnosing Unexplained Syncope in Clinical Practice. Clin Cardiol 32, 1; 28-31(2009).

2. Villar AV, Llano M, Cobo M, Expósito V, Merino R, Martín-Durán R, Hurlé MA, Nistal JF. Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy. J Mol Cell Cardiol 2009; 46: 526-535.

3. De la Torre-Hernández JM, García-Camarero T, Burgos-Palacios V, Ruiz-Lera M, Llano-Cardenal M, Expósito V, Sáinz-Laso F, Dae-Hyun Lee, Figueroa A, Zueco J. Impact of drug eluting stents on the clinical practise of revascularization of coronary artery disease. Eurointervention 2009; 5: 460-464.

4. Villar AV, Cobo M, Llano M, Montalvo C, González-Vílchez F, Martín-Durán R, Hurlé MA, Nistal JF. Plasma levels of transforming growth factor-beta1 reflect left ventricular remodeling in aortic stenosis. PLoS One. 2009 Dec 30;4(12):e8476.

5. José M. de la Torre Hernández, José A. Vázquez de Prada, Virginia Burgos, Fermín Sainz Laso, Mónica Fernández Valls, Francisco González Vilchez, Miguel Llano, Javier Ruano, Javier Zueco, Thierry Colman, Rafael Martín Duran. Virtual Histology Intravascular Ultrasound Assessment of Cardiac Allograft Vasculopathy From 1 to 20 Years After Heart Transplantation. J Heart Lung Transplant 2009;28:156–62.

6. Fernández-Sabé N, Cervera C, López-Medrano F, Llano M, Sáez E, Len O, Fortún J, Blanes M, Laporta R, Torre-Cisneros J, Gavaldà J, Muñoz P, Fariñas MC, María Aguado J, Moreno A, Carratalà J. Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis. 2009 Oct 15;49(8):1153-9.

7. Berrazueta JR, Gómez de Berrazueta JM, Amado Señarís JA, Peña Sarabia N, Fernández Viadero C, García-Unzueta MT, Sáez de Adana M, Sánchez Ovejero CJ, Llorca J. A diet enriched with mackarel (Scomber scombrus) derived products improves the endothelial function in a senior population. (Prevención de las Enfermedades Cardiovasculares: Estudio Santoña – PECES project) Eur J Clin Invest 2009; 39 : 165–173.

8. Roberto J. Cubeddu, Quynh A. Truong, Pablo Rengifo-Moreno, Tamara García-Camarero, David R. Okada, Thomas J. Kiernan, Ignacio Inglessis, Igor F. Palacios. Directional Coronary Atherectomy: a time for reflexion. Should we let it go? Eurointervention 2009;5:485-493.

9. Roig E, Almenar L, González-Vílchez F, et al. Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the spanish registry for heart transplantation. Am J Transplant. 2009; 9: 1414-1419.

10. Crespo-Leiro M, Delgado J, Almenar L, Arizón JM, Blasco T, Brossa V, De la Fuente L, Díaz B, Fernández-Yañez J, Garrido IP, Gómez Bueno M, González Vílchez F, et al. Steroid Use in Heart Transplant Patients in Spain in the Current Era: A Multicenter Survey. Transplantation Procceedings 2009; 41: 2244-2246.

11. Juan F. Delgado Nicolás Manito, Javier Segovia, Luis Almenar, José M. Arizón, Marta Campreciós, Maria G. Crespo-Leiro, Beatriz Díaz, Francisco González-Vílchez, Sònia Mirabet, Jesús Palomo, Eulàlia Roig, José M. de la Torre. The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation. Transplantation Reviews 2009;23:69-79

12. Crespo-Leiro MG, Delgado JF, Paniagua MJ, Vázquez, de Prada JA, Fernández-Yañez J, Almenar L, Díaz-Molina B, Roig E, Arizón JM, Alonso-Pulpón L, Garrido IP, Sanz ML, de la Fuente L, Mirabet S, Manito N, Muñiz. Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate. Clin Transplant 2009 DOI: 10.1111/j.1399-0012.2009.01178.x.

2

13. José M. de la Torre Hernández. Late acquired incomplete stent apposition: incidence, mechanisms and clinical implications. Eurointervention 2009; Vol 5: Suppl D : 112-120.

14. Full LE, Ruisanchez C, Monaco C. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther. 2009;11(2):217. Epub 2009 Apr 3. Review.

15. Expósito V, García-Camarero T, Bernal J, Arnáiz E, Sarralde A, García I, Berrazueta JR, Revuelta JM. Reintervenciones reiterativas sobre la válvula mitral. 30 años de experiencia. Rev Esp Cardiol 2009; 62(8):929-32.

16. Berrazueta JR. Estrés y Cardiopatía. Una relación peligrosa. Corazón y Salud. 2009; 58: 30-32.

17. García-Castro M, Coto E, Reguero JR, Berrazueta JR, Álvarez V, Alonso B, Sainz R, Martín M, and Morís C. Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol 2009; 62:48-56.

18. Íñigo Lozano, Tamara García-Camarero, Pilar Carrillo, José A. Baz, José M. de la Torre, Ramón López-Palop, Eduardo Pinar, Neus Salvatella, Pablo Avanzas y Mariano Valdés. Comparación de los stents liberadores de fármaco y los convencionales en puentes de safena. Resultados inmediatos y a largo plazo. Rev Esp Cardiol. 2009 Jan; 62 (1):39-47.

19. Rodríguez-Entem F, Expósito V, González-Enríquez S, García-Camarero T, Olalla J. Atrial flutter after heart transplantation: mechanism and catheter ablation. Transplantation Proceedings 2010; 42: 2697-2701.

20. Berrazueta JR, Guerra AR, García-Unzueta MT ,Martín Toca G; Sainz Laso R, Sáez de Adana M, Casanova Martín M, Cobo M, LLorca J. Endothelial Dysfunction, measured by reactive hyperemia using strain-gauge plethysmography, is an independent Predictor of Adverse Outcome in Heart Failure. EUR J Heart F 2010;12: 484-491. doi:10.1093/eurjhf/hfq036.

21. Coto E, Palacin M, Martín M, Castro MG, Reguero JR, Garcia C, Berrazueta JR, Moris C, Morales B, Ortega F , Corao AI , Diaz M, Tavira B, Alvarez V. Functional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier. Journal of Translational Medicine 2010, 8:64. doi:10.1186/1479-5876-8-64.

22. Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-del Blanco B, Martia G, Cascant P, Martín-Yuste V, Brugaletta S, Sabate M, Alfonso F, Capote ML, De La Torre JM, Ruíz-Lera M, Sanmiguel M, Cardenas M, Pujol B, Baz JÁ, Iñiguez A, Trillo R, Gonzalez-Bejar O, Casanova J, Sanchez-Gila J, Garcia-Dorado D. Background, incidence and predictor s of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation. Circulation 2010; 122:1017-1025.

23. Manito N, Delgado JF, Crespo-Leiro MG, González-Vílchez F, Almenar L, Arizón JM, Díaz B, Fernández-Yáñez J, Mirabet S, Palomo J, Rodríguez Lambert JL, Roig E, Segovia J. Clinical recommendations for the use of everolimus in heart transplantation. Transplant Rev. 2010; 24: 129-42.

24. Delgado JF, Crespo-Leiro MG, Gómez-Sánchez MA, Paniagua MJ, González-Vílchez F, Vázquez de Prada JA, Fernández-Yáñez J, Pascual D, Almenar L, Martínez-Dolz L, Díaz B, Roig E, Segovia J, Arizón JM, Garrido I, Blasco T, López J, Brossa V, Manito N, Muñiz J. Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: results from the CAPRI study. Clin Transplant. 2010; 24 (5): 194-200.

25. Crespo-Leiro MG, Alonso-Pulpón LA, Villa-Arranz A, Brossa-Loidi V, Almenar Bonet L, González-Vílchez F, et al. The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: Data from the Spanish post-heart transplant tumour registry. Transplantation Procceedings 2010; 42: 3011-3013.

26. González-Vilchez F, Almenar L, Arizón JM, Mirabet S, Delgado JF, Diez de Molina B, et al. Temporal trends in the use of proliferation signal inhibitors in maintenance heart transplantation: a Spanish multicenter study. Transplant Proc. 2010; 42: 2997-3000.

3

27. Molina BD, Leiro MG, Pulpón LA, Mirabet S, Yañez JF, Bonet LA, Vílchez FG, et al. Incidence and risk factors for nonmelanoma skin cancer after heart transplantation. Transplant Proc. 2010; 42: 3001-5.

28. Delgado JF, Manito N, Almenar L, Crespo-Leiro M, Roig E, Segovia J, Vázquez de Prada JA, Lage E, Palomo J, Campreciós M, Arizón JM, Rodríguez-Lambert JL, Blasco T, De La Fuente L, Pascual D, Rábago G.Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study. Transpl Infect Dis. 2010 Oct 5. doi: 10.1111/j.1399-062.2010.00573.x.

29. Jose M de la Torre, et al. on behalf of the ESTROFA-2 group. Thrombosis of second generation drug-eluting stents in real practice. Results from the multicenter spanish registry ESTROFA-2. (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos de segunda generacion). J Am Coll Cardiol Intv 2010;3:911-9.http://www.ncbi.nlm.nih.gov/pubmed/20404254

30. Bernal JM, Pontón A, Diaz B, Llorca J, García I, Sarralde JA, Gutiérrez-Morlote J, Pérez-Negueruela C, Revuelta JM.Combined mitral and tricuspid valve repair in rheumatic valve disease: fewer reoperations with prosthetic ring annuloplasty. Circulation. 2010 May 4;121(17):1934-40.

31. Muñiz J, Gómez-Doblas JJ, Santiago-Pérez MI, Lekuona-Goya I, Murga-Eizagaetxebarría N, de Teresa-Galván SS E, Cruz-Fernández JM, Castro-Beiras A; CAM2 Project working group. The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial. Health Qual Life Outcomes. 2010 Nov 22;8:137.

32. Zimbarra Cabrita I, Ruisanchez C, Dawson D, Grapsa J, North B, Howard LS,Pinto FJ, Nihoyannopoulos P, Gibbs JS. Right ventricular function in patients with pulmonary hypertension; the value of myocardial performance index measured by tissue Doppler imaging. Eur J Echocardiogr. 2010 Sep;11(8):719-24. doi:10.1093/ejechocard/jeq051. Epub 2010 Apr 21. PubMed PMID: 20410189.

33. Velázquez MT, Albarrán A, Hernández F, García Tejada J, Zueco J, Andreu J, De la Torre JM, Figueroa A, Saínz F, Tascón J. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study. Acta Cardiol. 2010;65:387-94.

34. Alonso-Valle H, Fariñas-Álvarez C, Bernal-Marco JM, José García-Palomo D, Gutiérrez-Díez F, Martín-Durán R, Berrazueta JR de, González-Macías F, Revuelta-Soba JM, Fariñas MC. Cambios en el perfil de la endocarditis sobre válvula protésica en un hospital de tercer nivel: 1986-2005. Rev Esp Cardiol. 2010;63:28-35.

35. Almenar L, Segovia J, Crespo-Leiro MG, Palomo J, Arizón JM, González-Vílchez F, et al. Registro Español de Trasplante Cardiaco. XXI Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2009). Rev Esp Cardiol.2010; 63 :1317-28.

36. José F. Díaz, José M. de la Torre, Manel Sabaté, Javier Goicolea. Registro Español de Hemodinámica y Cardiología Intervencionista. XIX Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2009) Rev Esp Cardiol.2010; 63 :1304-16.

37. De la Torre Hernández JM, Gorria GM, Vázquez de Prada JA, Zueco J. Papillary muscle rupture: First report of this complication in a retrograde transfemoral aortic valve implantation. Catheter Cardiovasc Interv. 2011;78(4):647-9.

38. Pablo Salinas, Guillermo Galeote, Roberto Martín-Reyes, María J. Pérez-Vizcayno, Rosana Hernández-Antolín, Vicente Mainar, José Moreu, José M. de la Torre, Javier Zueco, et al. Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: results from a Spanish multicentre registry. Eurointervention 2011;6:1-5

4

39. Villar AV, Merino D, Wenner M, Llano M, Cobo M, Montalvo C, García R, Martín-Durán

R, Hurlé JM, Hurlé MA, Nistal JF. Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjuction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis. Heart. 2011 Jul;97(14):1132-7.

40. Durst R, Avelar E, McCarty D, Poh KK, Friera LF, Llano MF, Chu J, Anumandla AK, Rodriguez LL, Mack MJ, Hanzel G, Kodali SK, Hung J, Picard MH. Outcome and improvement predictors of mitral regurgitation after transcatheter aortic valve implantation. J Heart Valve Dis. 2011 May;20(3):272-81.

41. Gonzalez-Vílchez F, Vázquez de Prada J.A., Canteli A., Castrillo C., Llano M., Martín Duran R. Predictors of Long Term Renal Function after Conversion to Proliferation Signal Inhibitors in Long-Term Heart Transplant Recipients. J Heart Lung Transplant. 2011 May;30(5):552-7.

42. de la Torre Hernández JM, Hernández Hernández F, Alfonso F, Rumoroso JR, López-Palop R, Sadaba M, Carrillo P, Rondán J, Lozano I, Ruiz Nodar JM, Baz JA, Fernandez Nofrerias E, Pajín F, García Camarero T, Gutierrez H; LITRO Study Group (Spanish Working Group on Interventional Cardiology). Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. J Am Coll Cardiol. 2011 Jul 19;58(4):351-8.

43. M.G. Crespo-Leiro, A. Villa-Arranz, N. Manito-Lorite, M.J. Paniagua-Martín, G. Rábago, L. Almenar-Bonete, L. Alonso-Pulpón, S. Mirabet-Pérez, B. Díaz-Molina, F. González-Vílchez, J.M. Arizón de Prado, N. Romero-Rodríguez, J. Delgado-Jiménez, E. Roig, T. Blasco-Peiró, D. Pascual-Figal, L. De la Fuente Galán, J. Muñíz. Lung cancer after heart transplantation: Results from a large multicenter Registry. Am J Transplant. 2011; 11: 1035-1040.

44. González-Vílchez F, Vázquez de Prada JA. The role of pre-conversion glomerular filtration rate in predicting long-term renal function after conversion to proliferation signal inhibitors in long-term heart transplant recipients. J Heart Lung Transplantation 2011; 30: 1302. (letter).

45. Lozano I, Cuellas C, Avanzas P, de Prado AP, Suárez C, Rondán J, Lee D, de la Hera JM, Fernández F, Morís C. Cobalt-Chromium Stents in Long Lesions of Large Vessels. Clnical and Angiographic Results. Tex Heart Inst J. 2011; 38: 35-41.

46. Almenar L, Segovia J, Crespo-Leiro MG, Palomo J, Arizón JM, Cobo M, Delgado J; Equipos Españoles de Trasplante Cardiaco. Registro Español de Trasplante Cardiaco. XXII Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2010). Rev Esp Cardiol. 2011 Dec;64(12):1138-46.

47. José M. de la Torre Hernández, José F. Díaz Fernández, Manel Sabate Tenas y Javier Goicolea Ruigómez. Actualización en cardiología intervencionista. Rev Esp Cardiol.2011; 64(Supl.1) :13-9.

48. Díaz JF, de la Torre JM, Sabaté M, Goicolea J. Spanish cardiac catheterization and coronary intervention registry. 20th official report of the spanish society of cardiology working group on cardiac catheterization and interventional cardiology (1990-2010)]. Rev Esp Cardiol. 2011 Nov;64(11):1012-22.

49. Expósito V, Rodríguez-Entem F, González-Enríquez S, Olalla J. Droneradone for recurrent ventricular tachycardia: a real alternative?. Indian Pacing Electrophysiol J 2012; Mar, 12(2): 73-6.

50. S. González-Enríquez, F. Rodríguez-Entem, V. Expósito, C. Castrillo-Bustamante, A. Canteli, A. Solloso, I. Madrazo, J. J. Olalla. Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better?. JICE 2012;35:343-349.

5

51. Villar AV, Merino D, Wenner M, Llano M, Cobo M, Montalvo C, García R, Martín-Durán

R, Hurlé JM, Hurlé MA, Nistal JF. Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjunction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis. Heart. 2011 Jul;97(14):1132-7 doi:10.1136/ hrt.2010.220418.

52. Montalvo C, Villar AV, Merino D, García R, Ares M, Llano M, Cobo M, Hurlé MA, Nistal JF. Androgens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-β”. PlosOne. En prensa. DOI: 10.1371/journal.pone.0035635.

53. Villar AV, García R, Merino D, Llano M, Cobo M, Montalvo C, Martín Durán M, Hurlé MA, Nistal JF. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int J Cardiol (2012), http://dx.doi.org/10.1016/j.ijcard.2012.07.021.

54. Yared K, Garcia-Camarero T, Fernandez-Friera L, Llano M , Durst R, Reddy A.A, O’Neill W.W, Picard M. H. Impact of Aortic Regurgitation After Transcatheter Aortic Valve Implantation. Results From the REVIVAL Trial. JACC: Cardiovascular Imaging 2012; 5(5): 469-477.

55. Francisco González-Vílchez, José Antonio Vázquez de Prada, Luis Almenar, José María Arizón del Prado, Sonia Mirabet, Beatriz Díaz-Molina, Juan Francisco Delgado, Manuel Gómez-Bueno, María Jesús Paniagua, Félix Pérez-Villa, Eulalia Roig, Luis Martínez-Dolz, Vicens Brossa, José Luis Lambert, Javier Segovia, María Generosa Crespo-Leiro, María Jesús Ruiz-Cano. Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation. J Heart Lung Transplat. 2012; 31: 288-295.

56. Paniagua Martín MJ, Almenar L, Brossa V, Crespo-Leiro MG, Segovia J, Palomo J, Delgado J, González-Vílchez F, Manito N, Lage E, García-Guereta L, Rodríguez-Lambert JL, Albert DC. Transplantation for complex congenital heart disease in adults: a subanalysis of the Spanish Heart Transplant Registry. Clin Transplant. 2012; 26: 755-763.

57. Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, González-Vílchez F, Almenar L, et al. Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency. Am J Transplant 2012; 12 (9): 2487-2497.

58. Crespo Leiro MG, Bonet LA, Paniagua Martín MJ, Gómez Bueno M, Escribano P, González Vílchez F, Rodríguez Lambert JL, Brossa Loidi V, Lage Gallé E, Delgado Jiménez J. Steroid withdrawal during 5 years following heart transplantation and the relationship between steroid dosage at 1-year follow-up and complications during the next 2 years: results from the RESTCO study. Transplant Proc. 2012; 44: 2631-4.

59. Val-Bernal JF, Neira C, Nistal JF, González-Vílchez FJ, González-Gay JM, Val D. Simultaneous papillary fibroelastomas of the pulmonary and aortic valves. Pathol Res Pract. 2012; 208: 315-317.

60. D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernández JM, et al. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol. 2012 Feb 21. [Epub ahead of print].

61. Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Masotti-Centol M, Carrillo X, Mauri J, Batalla N, Larrousse E, Martín E, Serra A, Rumoroso JR, Ruiz-Salmerón R, de la Torre JM, Cequier A, Gómez-Hospital JA, Alfonso F, Martín-Yuste V, Sabatè M, García-Dorado D. Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year. J Am Coll Cardiol. 2012 Oct 9;60(15):1333-9.

6

62. Ibañez B, Fuster V, Macaya C, Sánchez-Brunete V, Pizarro G, López-Romero P, Mateos

A, Jiménez-Borreguero J, Fernández-Ortiz A, Sanz G, Fernández-Friera L, Corral E, Barreiro MV, Ruiz-Mateos B, Goicolea J, Hernández-Antolín R, Acebal C, García-Rubira JC, Albarrán A, Zamorano JL, Casado I, Valenciano J, Fernández-Vázquez F, de la Torre JM, Pérez de Prado A, Iglesias-Vázquez JA, Martínez-Tenorio P, Iñiguez A. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction. Am Heart J. 2012 Oct;164(4):473-480.

63. Fernández-Valls M., Arnaíz J. Canga A., M-Durán R. Images in Cardiology. Double aortic arch presents with dysphagia as initial symptom. JACC Vol.60 Issue 12 p.1114 Sept.2012 .

64. Anguita M, Comín J, Almenar L, Crespo M, Delgado J, González-Costello J, Hernández-Madrid A, Manito N, Pérez de la Sota E, Segovia J, Segura C, Alonso-Gómez AM, Anguita M, Cequier A, Comín J, Díaz-Buschmann I, Fernández-Lozano I, Fernández-Ortiz A, Gómez de Diego JJ, Pan M, Worner F, Alonso-Pulpón L, Bover R, Castro A, Díaz-Molina B, Gómez-Bueno M, González-Juanatey JR, Lage E, López-Granados A, Lupón J, Martínez-Dolz L, Muñoz R, Pascual D, Ridocci F, Roig E, Varela A, Vázquez de Prada JA. Comments on the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed). 2012;65:874-8.

65. Almenar L, Segovia J, Crespo-Leiro MG, Palomo J, Arizón JM, González-Vílchez F, et al. Registro Español de Trasplante Cardiaco. XXIII Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2011). Rev Esp Cardiol. 2012; 65: 1030-1038.

66. José M. de la Torre Hernández, José F. Díaz Fernández, Manel Sabate Tenas y Javier Goicolea Ruigómez. Actualización en cardiología intervencionista. Rev Esp Cardiol.2012; 65(Supl.1) :4-11.

67. José M. de la Torre Hernández, Stephan Windecker. Trombosis muy tardía con nuevos stents farmacoactivos: ¿ha dejado de ser un asunto relevante?. Rev Esp Cardiol. 2012;65:595-8.

68. Díaz JF, de La Torre JM, Sabaté M, Goicolea J. Spanish Cardiac Catheterization and Coronary Intervention Registry. 21st official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2011). Rev Esp Cardiol. 2012 Dec;65(12):1106-16.

69. Rabanal Llevot, J.M.; Cimadevilla Calvo, B.; Cifrián Martínez, J.M.; Ruisánchez Villar, C.; Mons Lera, R Efecto de iloprost nebulizado combinado con óxido nítrico inhalado y sildenafilo oral en las presiones pulmonares de pacientes sometidos a trasplante pulmonar. Eficacia terapéutica en la hipertensión pulmonar intraoperatoria. Rev Esp Anestesiol Reanim.2012; 59 :142-9 - vol. 59 núm 03 CLAVE A.

70. D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernandez JM, et al. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol. 2013 Jul 31;167(2):575-84.

71. De la Torre Hernández JM, Alfonso F, Recalde AS, Jiménez Navarro MF, Pérez de Prado A, Hernández F, Abdul-Jawad Altisent O, Roura G, Camarero TG, Elizaga J, Rivero F, Gimeno F, Calviño R, Moreu J, Bosa F, Rumoroso JR, Bullones JA, Gallardo A, Fernández Díaz JA, Ruíz Arroyo JR, Aragón V, Masotti M; ESTROFA-LM Study Group. Comparison of Paclitaxel-Eluting Stents (Taxus) and Everolimus-Eluting Stents (Xience) in Left Main Coronary Artery Disease With 3 Years Follow-Up (from the ESTROFA-LM Registry). Am J Cardiol. 2013 Mar 1;111(5):676-83.

7

72. Cascón-Pérez JD, de la Torre-Hernández JM, Ruiz-Abellón MC, Martínez-Pascual M,

Mármol-Lozano R, López-Candel J, Cano P, Fernández C, Ramos JL, Villegas M, Picó-Aracil F. Characteristics of culprit atheromatous plaques obtained in vivo by intravascular ultrasound radiofrequency analysis: results from the CULPLAC study. Am Heart J. 2013 Mar;165(3):400-7.

73. José M. de la Torre Hernández, MD, PhD, Tamara García Camarero, MD, Piedad Lerena, MD, Dae-Hyun Lee, MD, Fermín Saínz Laso, MD, Gonzalo Martín Gorria, MD, Javier Zueco, MD. A real all-comers randomized trial comparing xience prime and promus element stents. J Invasive Cardiol. 2013 ;25:182-5.

74. de la Torre Hernández JM, López-Palop R, Garcia Camarero T, Carrillo Sáez P, Martin Gorria G, Frutos Garcia A, Arnáez Corada B, Cordero Fort A, Gómez Delgado JM, Agudo Quilez P, Lee DH, Mateo Rodríguez I, Saínz Laso F, Khashaba A, Miralles Arques S, Zueco Gil J. Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approach. EuroIntervention. 2013 Nov 22;9(7):824-30.

75. De la Torre Hernández JM, Lee DH, García-Camarero T, Saínz Laso F, Zueco J. Comparison of paclitaxel-eluting vs. everolimus-eluting stents implanted simultaneously in different lesions of the same coronary artery: 12-month follow-up with optical coherence tomography. EuroIntervention. 2013 Dec 23;9(8):952-8.

76. Ibañez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodríguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Pérez de Prado A, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Effect of Early Metoprolol on Infarct Size in ST-Segment-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial. Circulation. 2013 Oct 1;128(14):1495-1503. Epub 2013 Sep 3.

77. Felipe J. Rodríguez-Entem, Víctor Expósito, Susana González-Enríquez, Juan José Olalla-Antolín. Cryoablation versus radiofrequency ablation for the treatment of atrioventricular nodal reentrant tachycardia: results of a prospective randomized study. JICE 2013; 36:41–45.

78. Expósito V, Guzmán JC, Orava M, Armaganijan L, Morillo CA. Usefulness of Calgary Syncope Symptom Score for the diagnosis of vasovagal syncope in the elderly. Europace 2013; Aug;15(8):1210-4.

79. Expósito V, González-Enríquez S, Hevia N, Rodríguez-Entem F, Arnáez B, Olalla JJ. Sensado de miopotenciales en paciente portador de DAI: ¿Cuál es el mecanismo?. Revista Iberoamericana Arritmología, 2013. Jun 13 Vol. 4 No. 1, 35-9.

80. Lacunza FJ, Moya A, Martínez-Alday J, Barón G, Ruiz Granell R, Rivas N, González-Enríquez S, Leal J, Arcocha MF, Pérez Villacastín J, García Heil N, García-Arberola A. Implantable loop recorder allows an etiologic diagnosis in one third patients. Results of the Spanish Reveal Registry. Circ J 2013; 77(10); 2535-41.

81. Afilalo J, Flynn AW, Shymony A, Rudski LG, Agnihotri AK, Morin JF, Castrillo C, Shahian DM, Picard MH. “Incremental value of the preoperative echocardiogram to predict mortality and major morbidity in coronary artery bypass surgery”. Circulation 2013 Jan 22;127(3):356-64

82. Flynn AW, Afilalo J, Agnihotri AK, Castrillo C, Shahian DM, Picard MH. “Aortic sclerosis is associated with mortality and major morbidity in patients undergoing coronary artery bypass surgery”. Heart 2013 Feb;99(4):247-52.

8

83. García R, Villar A, Cobo M, Llano M, Martín Durán R, Hurle M, Nistal JF. “Circulating

levels of mi-R133a predict the regression potential of the left ventricular hypertrophy after valve replacement in patients with aortic stenosis. J Am Heart Assoc. 2013;2:e000211doi:10.1161/JAHA.113.000211.

84. Villar A, García R, Llano M, Cobo M, Merino D, Lantero A, Tramullas M, Hurle JM, Hurle M, Nistal JF. “BMP and activein membrane bound inhibitor protects the murine heart from pressure overload biomechanical stress by restraining TGF-ß signaling”. Biochimica et Biophysica Acta 1832. 2013: 323-335.

85. Villar A, García R, Merino D, Llano M, Cobo M, Montalvo C, Martín Durán R, Hurle M, Nistal JF. “Myocardial and circulating levels of microRNA21 reflect left ventricular fibrosis in aortic stenosis patients”. Int J Cardiol. 2013 Sep 10;167(6):2875-81.

86. Zimbarra Cabrita I, Ruísanchez C, Grapsa J, Dawson D, North B, Pinto FJ, Gibbs JS, Nihoyannopoulos P. Validation of the isovolumetric relaxation time for the estimation of pulmonary systolic arterial blood pressure in chronic pulmonary hypertension. Eur Heart J Cardiovasc Imaging. 2013 Jan;14(1):51-5. doi: 10.1093/ehjci/jes093. Epub 2012 May 15. PubMed PMID: 22588209.

87. Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, Gonzalez-Vílchez F, Villa-Arranz A, Delgado-Jiménez J, Lage-Galle E, Pérez-Villa F, Lambert-Rodríguez JL, Manito-Lorite N, Arizon-Del Prado JM, Brossa-Loidi V, Pascual-Figal D, Fuente-Galán L, Sanz-Julve M, Muñiz-Garcia J, Crespo-Leiro M. Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry. Circ Heart Fail. 2013 Jul;6(4):763-72. doi: 10.1161/CIRCHEARTFAILURE.112.000237. Epub 2013 May 14.

88. Cosío Carmena MD, Gómez Bueno M, Almenar L, Delgado JF, Arizón JM, González Vílchez F, Crespo-Leiro MG, Mirabet S, Roig E, Pérez Villa F, Fernández-Yañez JF, Lambert JL, Manito N, Fuente L, Sanz Julve ML, Pascual D, Rábago G, Millán I, Alonso-Pulpón LA, Segovia. Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score. J. Heart Lung Transplant. 2013 Dec;32(12):1187-95. doi: 10.1016/j.healun.2013.08.004.

89. González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Gómez-Bueno M, Arizón JM, Almenar L, Roig E, Delgado J, Lambert JL, Pérez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, López-Granados A, Martínez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?. Int J Cardiol. 2014 Jan 15;171(1):15-23. doi: 10.1016/j.ijcard.2013.11.036. Epub 2013 Nov 23.

90. González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Almenar L, Mirabet S, Gómez-Bueno M, Díaz-Molina B, Arizón JM, Delgado J, Pérez-Villa F, Crespo-Leiro MG, Martínez-Dolz L, Roig E, Segovia J, Lambert JL, Lopez-Granados A, Escribano P, Farrero M. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation. Clin Transplant. 2013 Nov-Dec;27(6):E649-58. doi: 10.1111/ctr.12241. Epub 2013 Sep 12.

91. Solís J, Piro V, Loughlin G, Vázquez de Prada JA. How to grade mitral regurgitation: an integrative approach. Cardiol Clin. 2013 May;31(2):169-75. doi: 10.1016/j.ccl.2013.04.002. Review.

92. Solis J, Piro V, Vázquez de Prada JA, Loughlin G. Echocardiographic assessment of mitral regurgitation: general considerations. Cardiol Clin. 2013 May;31(2):165-8. doi: 10.1016/j.ccl.2013.04.001. Review.

93. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Committees; RED-HF Investigators. ( Berrazueta Fernández JR, Principal investigator H. Valdecilla, Santander Spain).Treatment of anemia with darbapoetin alfa in systolic heart failure. N Engl J Med. 2013;368:1210-9. doi: 10.1056/NEJM.

9

94. McMurray JJ, Anand IS, Díaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD,

Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; RED-HF Committees Investigators ( Berrazueta Fernández JR, Principal investigator H. Valdecilla, Santander Spain). Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). Eur J Heart Fail. 2013;15:334-41.

95. José M. de la Torre Hernández, José F. Díaz Fernández, Manel Sabate Tenas y Javier Goicolea Ruigómez. Actualización en cardiología intervencionista. Rev Esp Cardiol. 2013;66:282-9.

96. Rodríguez Entem F, González Enríquez S, Expósito V, Olalla JJ. La Unidad de Sincope. Cuadernos de Estimulación Cardíaca. 2013; 103-110.

97. Fradejas Sastre V, Pérez Velasco P. Importancia de una comunidad educativa formada en técnicas de reanimación cardiopulmonar. Cuidados Intensivos Cardiológicos. Nuber Científ. 2013;2(10): 13-17.

98. González-Vílchez F, Gómez-Bueno M, Almenar L, Crespo-Leiro MG, Arizón JM, Martínez-Sellés M, Delgado J, Roig E, Lage E, Manito N. Registro Español de Trasplante Cardiaco. 24

99. Informe Oficial de la Sociedad Española de Cardiología en Insuficiencia Cardiaca y Trasplante Cardiaco (1984-2012). Rev Esp Cardiol. 2013; 66:973-982 FI:.. 3204 [doi: 10.1016/j.recesp.2013.08.004].

100. Barge Caballero, E., Segovia-Cubero, J., Almenar Bonet, L., González-Vílchez, F., Villa-Arranz, A., Delgado-Jiménez, J., Lage-Galle, E. Pérez-Villa , F. Lambert-Rodríguez, JL, Crespo-Leiro, M. Emergencia cardiaca nuevo trasplante: ¿se justifica? Los datos del registro de trasplante cardíaco Nacional. Eur Heart J. 2013; 34:946-946.

101. Rábago, G., Almenar, L. Fernández-Vanez, J., Lage, E., Lambert, JL González-Vílchez, F. Crespo-Leiro, MG, Delgado, JF. Observacional Estudio Epidemiológico para evaluar el riesgo cardiovascular Factores en receptores de trasplantes de corazón en España (CTC Study): Resultados preliminares a los 18 meses después del trasplante. Transplante J Heart Lung. 2013; 32:205-206.

102. Coordinadores:, Worner F, Cequier A; Grupo de Trabajo de la Sociedad Española de Cardiología para la guía de práctica clínica sobre el síndrome coronario agudo con elevación del segmento ST:, Bardají A, Bodí V, Bover R, Martínez-Sellés M, Sabaté M, Sionis A, Vázquez de Prada JA; Grupo de Revisores Expertos para la guía de síndrome coronario agudo con elevación del segmento ST:, Arós F, Arribas F, Barrabés J, Díaz de Castro O, Heras M, López Palop R, López-Sendón JL, Manito N, de Pablo MC, Ripoll T, San Román A, de la Torre JM; Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología:, Fernández-Ortiz A, Alonso Gómez AM, Anguita M, Cequier A, Comín J, Díaz-Buschmann I, Fernández Lozano I, Gómez de Diego JJ, Pan M, Worner F. Comments on the ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation. Rev Esp Cardiol. 2013 Jan;66(1):5-11. doi: 10.1016/j.recesp.2012.10.013. Epub 2012 Dec 25. English, Spanish. No abstract available. Erratum in: Rev Esp Cardiol. 2013 Apr;66(4):329. Vázquez de Prada, Manuel [corrected to Vázquez de Prada, José Antonio].

103. De Belder A, de la Torre Hernandez JM, Lopez-Palop R, O'Kane P, Hernandez F, Strange J, Gimeno F, Cotton J, Diaz Fernandez J, Carrillo Saez P, Thomas M, Pinar E, Curzen N, Baz J, Cooter N, Lozano I, Skipper N, Robinson D, Hildick-Smith D. A Prospective Randomized Trial Of Everolimus-Eluting Stents Versus Bare Metal Stents In Octogenarians: Xience Or Vision Stents For The Management Of Angina In The Elderly - The Xima Trial. J Am Coll Cardiol. 2014; 63: 1371-5.

CONTINÚA EN SIGUIENTE PÁGINA

10

104. Jose M de la Torre Hernandez, José Antonio Baz Alonso, Joan Antoni Gómez Hospital, Fernando Alfonso, Tamara Garcia Camarero, Federico Gimeno de Carlos, Gerard Roura Ferrer, Angel Sanchez Recalde, Íñigo Lozano Martínez-Luengas, Josep Gomez Lara, Felipe Hernandez, María José Pérez-Vizcayno, Angel Cequier Fillat, Armando Perez de Prado, Agustín Albarrán, Manuel Jimenez Navarro, Josepa Mauri, Jose A Fernandez Diaz, Eduardo Pinar, Javier Zueco. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: patient level pooled analysis of 4 registries. J Am Coll Cardiol Intv. 2014;7:244-54.

105. Valgimigli M, Sabaté M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, Cequier A, Eberli F, de Belder A, Serruys PW, Ferrante G. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis. BMJ. 2014 Nov 4;349:g6427.

106. Dominguez-Rodriguez A, Abreu-Gonzalez P, Del Mar Garcia-Saiz M, Aldea-Perona A, de la Torre JM, Garcia-Camarero T, Consuegra-Sanchez L; on behalf of the MARIA Study Investigators. Cardioprotection with melatonin in the acute myocardial infarction: Awaiting results of MARIA trial ?. Int J Cardiol. 2014 Dec 30;182C:54-55.

107. Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, de Prado AP, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster VResponse to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial". Circulation. 2014 Jul 15;130(3):e19-20.

108. De la Torre Hernandez JM, Masotti Centol M, Lerena Saenz P, Sánchez Recalde A, Gimeno de Carlos F, Piñón Esteban P, Fernandez Rodriguez D, Sitges Carreño M, Sabate Tenas M, Zueco Gil J. Eficacia y seguridad a más de 10 años de la ablación septal percutánea en la miocardiopatía hipertrófica obstructiva. Rev Esp Cardiol. 2014;67:353-8.

109. De la Torre Hernández JM, Alfonso F, Martin Yuste V, Sánchez Recalde A, Jiménez Navarro MF, Pérez de Prado A, Hernández F, Abdul-Jawad Altisent O, Roura G, García Camarero T, Elizaga J, Calviño R, Moreu J, Bosa F, Jimenez Mazuecos J, Ruiz-Arroyo JR, García Del Blanco B, Rumoroso JR; en representación del grupo de estudio ESTROFA-IM. Comparacion de stents de Paclitaxol y stents de everolimus enel infartocon elevaciond el ST e influencia de la trombectomia en los resultados. Estudio ESTROFA-IM. Rev Esp Cardiol. 2014;67:999-1006.

110. González-Vílchez F, Gómez-Bueno M, Almenar L, Crespo-Leiro MG, Arizón JM, Palomo J, Delgado J, Roig E, Lage E, Manito N; Spanish Heart Transplantation Teams.Spanish Heart Transplantation Registry. 25th official report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2013). Rev Esp Cardiol (Engl Ed). 2014 Dec;67(12):1039-51.

111. González-Vílchez F, Vázquez de Prada JA. Chronic renal insufficiency in heart transplant recipients: risk factors and management options. Drugs. 2014 Sep;74(13):1481-94. doi: 10.1007/s40265-014-0274-9. Review.

112. Crespo-Leiro MG, Delgado-Jiménez J, López L, Alonso-Pulpón L, González-Vilchez F, Almenar-Bonet L, Rábago G, Pérez-Villa F, Paniagua Martín MJ, Arizón Del Prado JM, Sousa-Casasnovas I, Manito-Lorite N, Díaz-Molina B, Pascual-Figal D, Lage-Galle E, Blasco-Peiró T, De la Fuente-Galán L, Muñiz J. The falling incidence of hematologic cancer after heart transplantation. Clin Transplant. 2014 Oct;28(10):1142-7.

11

113. Barge-Caballero E, Almenar-Bonet L, Villa-Arranz A, Pérez-Villa F, Segovia-Cubero J, Delgado-Jiménez J, González-Vilchez F, Manito-Lorite N, De-la-Fuente-Galán L, Brossa-Loidi V, Lambert-Rodríguez JL, Pascual-Figal D, Lage-Gallé E, Arizón-Del-Prado JM, Sanz-Julve M, Muñiz-García J, Crespo-Leiro M. Impact of short-term mechanical circulatory support with extracorporeal devices on postoperative outcomes after emergency heart transplantation: data from a multi-institutional Spanish cohort. Int J Cardiol. 2014 Sep;176(1):86-93.

114. González-Vílchez F, Arizón JM, Segovia J, Almenar L, Crespo-Leiro MG, Palomo J, Delgado JF, Mirabet S, Rábago G, Pérez-Villa F, Díaz B, Sanz ML, Pascual D, de la Fuente L, Guinea G; ICEBERG Study Group. Chronic renal dysfunction in maintenance heart transplant patients: the ICEBERG study. Transplant Proc. 2014 Jan-Feb;46(1):14-20.

115. Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?. Int J Cardiol. 2014 Jan 15;171(1):15-23.

116. Arnáiz-García ME, Gutiérrez-Diez F, Arnáiz-García AM, Arnáiz J, Expósito V, Nistal JF, Rodríquez-Entem F, Olalla JJ, López-Rodríguez J, González-Santos JM. Successful retrieval of an irretrievable jugular tesio catheter using a fogarty arterial embolectomy catheter. Vasc Endovascular Surg. 2014 May;48(4):349-51.

117. De Belder A, de la Torre Hernandez JM, Lopez-Palop R, O'Kane P, Hernandez F, Strange J, Gimeno F, Cotton J, Diaz Fernandez J, Carrillo Saez P, Thomas M, Pinar E, Curzen N, Baz J, Cooter N, Lozano I, Skipper N, Robinson D, Hildick-Smith D. A Prospective Randomized Trial Of Everolimus-Eluting Stents Versus Bare Metal Stents In Octogenarians: Xience Or Vision Stents For The Management Of Angina In The Elderly - The Xima Trial. J Am Coll Cardiol. 2014; 63: 1371-5.

118. Jose M de la Torre Hernandez, José Antonio Baz Alonso, Joan Antoni Gómez Hospital, Fernando Alfonso, Tamara Garcia Camarero, Federico Gimeno de Carlos, Gerard Roura Ferrer, Angel Sanchez Recalde, Íñigo Lozano Martínez-Luengas, Josep Gomez Lara, Felipe Hernandez, María José Pérez-Vizcayno, Angel Cequier Fillat, Armando Perez de Prado, Agustín Albarrán, Manuel Jimenez Navarro, Josepa Mauri, Jose A Fernandez Diaz, Eduardo Pinar, Javier Zueco. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: patient level pooled analysis of 4 registries. J Am Coll Cardiol Intv. 2014;7:244-54.

119. Valgimigli M, Sabaté M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, Cequier A, Eberli F, de Belder A, Serruys PW, Ferrante G. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis. BMJ. 2014 Nov 4;349:g6427.

120. Dominguez-Rodriguez A, Abreu-Gonzalez P, Del Mar Garcia-Saiz M, Aldea-Perona A, de la Torre JM, Garcia-Camarero T, Consuegra-Sanchez L; on behalf of the MARIA Study Investigators. Cardioprotection with melatonin in the acute myocardial infarction: Awaiting results of MARIA trial ?. Int J Cardiol. 2014 Dec 30;182C:54-55.

121. Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, de Prado AP, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial". Circulation. 2014 Jul 15;130(3):e19-20.

12

122. De la Torre Hernandez JM, Masotti Centol M, Lerena Saenz P, Sánchez Recalde A,

Gimeno de Carlos F, Piñón Esteban P, Fernandez Rodriguez D, Sitges Carreño M, Sabate Tenas M, Zueco Gil J. Eficacia y seguridad a más de 10 años de la ablación septal percutánea en la miocardiopatía hipertrófica obstructiva. Rev Esp Cardiol. 2014;67:353-8.

123. De la Torre Hernández JM, Alfonso F, Martin Yuste V, Sánchez Recalde A, Jiménez Navarro MF, Pérez de Prado A, Hernández F, Abdul-Jawad Altisent O, Roura G, García Camarero T, Elizaga J, Calviño R, Moreu J, Bosa F, Jimenez Mazuecos J, Ruiz-Arroyo JR, García Del Blanco B, Rumoroso JR; en representación del grupo de estudio ESTROFA-IM. Comparacion de stents de Paclitaxol y stents de everolimus enel infartocon elevaciond el ST e influencia de la trombectomia en los resultados. Estudio ESTROFA-IM. Rev Esp Cardiol. 2014;67:999-1006.

124. Delgado JF, Oliva J, Llano M, Pascual-Figal D, Grillo JJ, Comín-Colet J, Díaz B, Martínez de La Concha L, Martí B, Peña LM. Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain. Rev Esp Cardiol (Engl Ed). 2014 Aug;67(8):643-50.